Abstract
These studies were designed to characterize dopamine receptor density and affinity in kidneys removed from sheep of varying ages (fetal, newborn, and adult) using radioligand binding methods. Three different radioligands were used: the specific dopamine-1 antagonist3H-SCH 23390, the dopamine-1/dopamine-2 antagonist3H-haloperidol, and the dopamine-2 antagonist3H-spiroperidol. The specific binding of3H-haloperidol and3H-spiroperidol was saturable with time and ligand concentration, being indicative of dopamine receptors. The specific binding of the dopamine-1 selective radioligand3H-SCH 23390 was also saturable with time but displayed several points of saturation with increasing ligand concentration. The specific binding of3H-haloperidol, which had a low affinity and is indicative of dopamine-1 receptors, showed no age-related changes in maximum receptor density or affinity. On the other hand, the maximum receptor density of dopamine-2 receptors measured by3H-spiroperidol decreased with age. The observations that renal dopamine-1 receptor density or affinity do not change with maturation are in agreement with our pervious studies that showed no age-related changes in dopamine-receptor-mediated renal vasodilatation in sheep. The significance of the decrease in renal dopamine-2 receptor density with age remains to be determined.
Similar content being viewed by others
References
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93–96
Felder RA, Carey RM (1987) Dopamine in cardiovascular function. In: Buckley JP, Ferrario CM (eds) Brain peptides and catecholamines in cardiovascular regulation in normal and disease states. Raven Press, New York, pp 79–91
Missale C, Pizzi M, Memo M, Picotti GB, Carruba MO, Spano PF (1985) Postsynaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries. Neurosci Lett 61:207–211
Brodde DE (1982) Vascular dopamine receptors: demonstration and characterization by in vitro studies. Life Sci 31: 289–306
Frederickson E, Bradley T, Goldberg LI (1985) Blockade of renal effects of dopamine in the dog by DA1 antagonist SCH 23390. Am J Physiol 249: F236–F240
Goldberg LI, Volkman PH, Kohli ID (1978) A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol 18: 57–79
Gootman N, Buckley BJ, Gootman PM, Nagelberg JS (1982) Age related effects of single injections of dopamine on cardiovascular function in developing swine. Dev Pharmacol Ther 4: 139–150
Vane DW, Weber TR, Careskey J, Grosfeld JL (1982) Systemic and renal effects of dopamine in the infant pig. J Surg Res 32: 477–483
Pelayo JC, Fildes RD, Jose PA (1984) Age-dependent renal effects of intrarenal dopamine infusion. Am J Physiol 247: R212–R216
Nakamura KT, Felder RA, Jose PA, Robillard JE (1987) Effects of dopamine in the renal vascular bed of fetal, newborn, and adult sheep. Am J Physiol 252: R490–R497
Robillard JE, Weitzman RE (1980) Developmental aspects of the fetal response to exogenous arginine vasopressin. Am J Physiol 238: F407–F414
Felder RA, Blecher M, Eisner GM, Jose PA (1984) Cortical tubular and glomerular dopamine receptors in the rat kidney. Am J Physiol 246: F557–F568
Snavely MD, Insel RA (1982) Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na+. Mol Pharmacol 22: 532–546
Huff RM, Molinoff PB (1982) Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci USA 79: 7561–7565
Christensen AV, Arnt J, Hyttel J, Larsen JJ, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540
Allesandrini C, Cavalotti C, Rossi M De, Fruschelli C, Gerli R, Mione MC, Sacchi G, Amenta F (1984) Localization of dopamine receptors in the rabbit renal artery: a histoautoradiographic study. Pharmacology 29: 17–23
Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468
Niznik HB, Otsuka Y, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P (1986) Dopamine D1 receptors characterized with (3H)SCH 23390. J Biol Chem 261: 8397–8406
Felder RA, Blecher M, Calcagno PL, Jose PA (1984) Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol 247: F499–F505
Rosenthal HE (1967) Graphic methods for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525–532
Lowry OH, Rosebrough NS, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265–268
Swann AC, Albers RW (1975). Sodium + potassium activated ATPase of mammalian brain regulation of phosphatase activity. Biochim Biophys Acta 382: 437–456
Bennett JP Jr. (1985) Neurotransmitter, hormone, or drug receptor binding methods. In: Yamamura HI, Enna SJ, Kuhar MJ (eds) Neurotrasmitter receptor binding, 2nd edn. Raven, New York, p 61
Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzyme reaction. Biochem Pharmacol 22: 3099–3108
Altar CA, Marien MR (1987) Picomolar affinity of125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography. J Neurosci 7: 213–222
Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA (1981) Renal alpha-1 and alpha-2 adrenergic receptor: biochemical and pharmacological correlations. J Pharmacol Exp Ther 30: 329–337
Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32: 229–313
Dowling JE, Watling KJ (1981) Dopaminergic mechanisms in the teleost retina. II. Factors affecting the accumulation of cyclic AMP in pieces of intact carp retina. J Neurochem 36: 569–579
Steinhausen M, Weis S, Fleming J, Dussel R, Parekh N (1986) Responses of in vivo renal microvessles to dopamine. Kidney Int 30: 361–370
Plantje JF, Hansen HA, Daus FJ, Stoof JC (1984) The effects of SCH 23390, YM 09151-2, (+)- and (−)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro. Eur J Pharmacol 105: 73–83
Pelayo JC, Fildes RD, Eisner GM, Jose PA (1983) The effects of dopamine blockade on renal sodium excretion. Am J Physiol 245: F247–F253
Chapman BJ, Horn NM, Munday KA, Robertson MJ (1980) The actions of dopamine and of sulpiride on regional blood flows in the rat kidney. J Physiol (Lond) 298: 437–452
McGrath B, Bode K, Luxford A, Howden B, Jablonski P (1985) Effects of dopamine on renal function in the rat isolated perfused kidney. Clin Exp Pharmacol Physiol 12: 343–352
Nakajima T, Naitoh F, Kuruma I (1977) Dopamine-sensitive adenylate cyclase in rat kidney particulate preparation. Eur J Pharmacol 41: 163–169
Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272: 168–171
Willcocks AL, Nahorski SR (1983) Binding of125I-iodohydroxy-benzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta adrenoceptors. Biochem Pharmacol 32: 3311–3319
Jose PA, Felder RA, Robillard JE, Felder CC, Eisner GM (1986) Dopamine-2 receptor in the canine kidney (Abstract). Kidney Int 29: 385